COR
Cencora Inc
NYSE · Health Care
$359.25
+7.09 (+2.01%)
Income Statement
| FY 2026 | FY 2025 | FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|---|---|
| Revenue | 320.21B | 289.96B | 61.09B | 64.56B | 50.79B |
| Net Income | 1.55B | 1.26B | 3.38B | 3.64B | 3.39B |
| EPS | — | — | — | — | — |
| Profit Margin | 0.5% | 0.5% | 5.5% | 5.6% | 6.7% |
| Rev Growth | +10.4% | +10.4% | +24.7% | +21.6% | +22.9% |
Balance Sheet
| FY 2026 | FY 2025 | FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|---|---|
| Total Debt | 29.20B | 29.20B | 4.06B | 3.76B | 4.55B |
| Total Equity | 5.75B | 5.75B | 23.90B | 26.18B | 25.95B |
| D/E Ratio | 5.08 | 5.08 | 0.17 | 0.14 | 0.18 |
Cash Flow
| FY 2026 | FY 2025 | FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|---|---|
| EBITDA | 3.59B | 3.09B | 6.39B | 6.65B | 4.98B |
| Free Cash Flow | — | — | 2.63B | 4.33B | 3.13B |